Clinical Trial Update: A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of BBI608 in combination with standard chemotherapies for adults with advanced gastrointestinal cancer completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• BBI608

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Advanced Gastrointestinal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-20